Today, Weibel Scientific announces its annual accounts for 2016/17. The gross profit of DKK 102 million is lower than the DKK 134 million in the record-breaking year 2015/16, but the number reflects Weibel’s further development of existing products and long-term investments in new technologies and markets.
“Last year’s accounts were exceptionally great and gave us the right foundation to invest in long-term projects. We have been able to focus on developing new systems to replace the ones we have delivered since 1988. We have lost zero contracts this year, because we continue to develop our product portfolio. This ensures us an important edge over our competitors,” says Weibel’s CEO, Peder R. Pedersen.